Microwave treatment of renal cell carcinoma adjacent to renal sinus
详细信息 查看全文
- 作者：Yongyan Gao ; M.D.a ; b ; gaoyongyan7@163.com" class="auth_mail" title="E-mail the corresponding author ; Ping Liang ; M.D.a ; liangping301@hotmail.com" class="auth_mail" title="E-mail the corresponding author ; Xiaoling Yu ; M.D.a ; 784107477@qq.com" class="auth_mail" title="E-mail the corresponding author ; Jie Yu ; M.D.a ; 1411495161@qq.com" class="auth_mail" title="E-mail the corresponding author ; Zhigang Cheng ; M.D.a ; 13691367317@163.com" class="auth_mail" title="E-mail the corresponding author ; Zhiyu Han ; M.D.a ; hanzhiyu122@163.com" class="auth_mail" title="E-mail the corresponding author ; Shaobo Duan ; M.D.a ; Dustin2662@163.com" class="auth_mail" title="E-mail the corresponding author ; Hui Huang ; M.D.a ; 309hh@sina.com" class="auth_mail" title="E-mail the corresponding author
- 关键词：Renal cell carcinoma ; Thermal ablation ; Microwave ; Renal pelvis
- 刊名：European Journal of Radiology
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：85
- 期：11
- 页码：2083-2089
- 全文大小：1103 K
文摘
- •
This study shows US-guided microwave ablation appears to be a promising method to treat renal cell carcinoma adjacent to renal sinus.
- •
The estimated 1-, 3- and 5-year RCC-related survival were 100%, 93.3% and 93.3%, respectively.
- •
The estimated 1-, 3- and 5-year overall survival were 97.1%, 87.8%, 83.6%, respectively.
- •
For patients with RCC ≤4 cm, initial ablation success was 100% (29/29) and the estimated 5-year disease-free survival were 81.5%.